NATtrol GBS Negative Control
The NATtrol Group B Streptococcus (GBS) Negative Control is an unassayed in vitro diagnostic external run control intended to be used with qualitative molecular assays for detection of nucleic acids from this organism. The control is intended to be used as an aid to diagnosis in that it is used to verify performance of the assays used to detect a physiological or pathological state. The routine and repetitive use of external run controls enables laboratories to monitor daily test variation, lot-to lot test kit performance, individual operator variation, and can provide assistance in identifying increases in random or systemic errors. NATtrol GBS Negative Control contains intact organisms and should be run in a manner identical to that used for clinical specimens. The control does not have an assigned value and it is the responsibility of the end user to establish their own target specifications for the control using their laboratory?s molecular procedures.
NATtrol GBS Negative Control is formulated with purified, intact organisms that have been chemically modified to render them non- infectious and refrigerator stable. Each NATtrol GBS Negative Control contains 6 x 0.5 mL vials of NATtrolTM Lactobacillus acidophilus formulated in a Purified Protein Matrix that is fully commutable with true clinical specimens
CE marked ; Platform : Cepheid GeneXpert ; Test : Group B Streptococcal (GBS) / +2° to +8° C.